Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
PLSE Transcript
Pulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Neutral5-13
Pulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call Transcript
Unknown5-8
The earnings call lacked substantial information on financial performance, strategic initiatives, or operational updates, leading to a neutral sentiment. The absence of clear guidance or significant announcements, combined with the acknowledgment of risks, does not indicate any strong market movement. Without explicit financial metrics or strategic developments, the stock price is unlikely to experience significant volatility.
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
Unknown2-20
The earnings call reveals mixed signals: strong revenue growth and positive reception of nPulse, but increased non-GAAP costs and cash burn raise concerns. The strategic focus on partnerships and regulatory progress is promising, yet the lack of clear timelines for product releases and the decline in cash reserves temper optimism. The market may react cautiously, resulting in a neutral stock price movement.
Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call highlights significant challenges: a GAAP net loss of $19.4 million, high cash burn, and competitive pressures. Despite initial revenue from product launches, financial sustainability is a concern. The Q&A reveals uncertainties in strategic partnerships and trial outcomes. These factors, coupled with increased costs and competitive risks, suggest a negative sentiment. Without strong guidance or partnerships, the stock is likely to face downward pressure.
PLSE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
